Verified Nov 2026
Other
·

Mumbai, Maharashtra
·
Since 1977
Glenmark Pharmaceuticals is an Indian multinational pharmaceutical company headquartered in Mumbai, founded in 1977. With 10,000-50,000 employees and estimated annual revenue of $1-5 billion, it operates in branded formulations, generics, active pharmaceutical ingredients, and specialty products across respiratory, dermatology, and oncology segments. The company secured exclusive multi-regional rights to aumolertinib from Hansoh Pharma in late 2025 and operates manufacturing facilities across India, the United States, Argentina, the Czech Republic, and Switzerland.
Glenmark Pharmaceuticals at a glance
Revenue
$1-5B
Est. band
Employees
10,000-50,000
Founded
1977
Headquarters
Mumbai, Maharashtra
Certifications
ISO 14001
Import activity
6206
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
6206
Named foreign suppliers
50
Top origins
India · Oman · Sri Lanka · Spain

Shared foreign counterparties do not establish that these companies buy from Glenmark Pharmaceuticals.
What this tells a buyer
The company recorded 6,206 shipments originating from India and sourced from 23 countries including Oman, Spain, Germany, and Singapore.
Glenmark holds ISO 14001 certification and operates drug discovery and development programs alongside its formulations and API manufacturing operations.
The company maintains operations in over 80 countries with approximately 15,800 to 16,300 employees and generated around $1.58 billion in revenue in 2024.
Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026
STABILITY SIGNALS
Established & active
49 years in operation (founded 1977).
6,206 US import shipments on record.
Holds ISO 14001 certification(s) per public sources.
Overview
Glenmark Pharmaceuticals is an Indian multinational pharmaceutical company headquartered in Mumbai, founded in 1977. With 10,000-50,000 employees and estimated annual revenue of $1-5 billion, it operates in branded formulations, generics, active pharmaceutical ingredients, and specialty products across respiratory, dermatology, and oncology segments. The company secured exclusive multi-regional rights to aumolertinib from Hansoh Pharma in late 2025 and operates manufacturing facilities across India, the United States, Argentina, the Czech Republic, and Switzerland.
At a glance
Attribute | Detail |
|---|---|
Founded | 1977 |
Headquarters | Mumbai, Maharashtra |
Employees | 10,000-50,000 |
Revenue | $1-5B (estimated) |
Certifications | ISO 14001 |
What Glenmark Pharmaceuticals makes
Glenmark holds ISO 14001 certification and operates drug discovery and development programs alongside its formulations and API manufacturing operations.
Products and capabilities described on the company's own site include LED (source: glenmarkpharma.com).
Certifications
Glenmark Pharmaceuticals is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 14001 — glenmarkpharma.com
Trade and customs footprint
The company recorded 6,206 shipments originating from India and sourced from 23 countries including Oman, Spain, Germany, and Singapore. US customs bill-of-lading records list 6206 inbound shipments across 50 foreign suppliers, with top origins including India · Oman · Sri Lanka · Spain.
Latest developments
2026-11-10 — Respiratory Today, Oncology Tomorrow: Glenmark Lines Up Its Next Chapter (citeline.com)
2026-11-05 — Glenmark Pharma Q2 Results: Net profit plunges 56% to Rs 264 crore, revenue down at Rs 4,247 cr - The Economic Times (economictimes.com)
2026-02-02 — Glenmark Pharmaceuticals Targets FY28 for Oncological Drug Market Launch and Margin Growth, ETPharma (indiatimes.com)
2026-01-22 — AcuCort signs commercial agreement with Glenmark Pharmaceuticals for Germany and five additional European countries – Acucort (acucort.se)
2025-12-16 — HANSOH PHARMA GRANTS GLENMARK EXCLUSIVE MULTI-REGIONAL RIGHTS REGARDING AUMOLERTINIB-Press Releases-Hansoh Pharmaceutical Group Co., Ltd. (hspharm.com)
2025-11-27 — Glenmark Pharma’s Monroe facility back on track as USFDA issues EIR with voluntary action indicated status - CNBC TV18 (cnbctv18.com)
Facilities
Glenmark Pharmaceuticals is headquartered in Mumbai, Maharashtra. Public sources also reference these locations:
Maharashtra, India — glenmarkpharma.com
Himachal Pradesh, India — glenmarkpharma.com
Company details
The company maintains operations in over 80 countries with approximately 15,800 to 16,300 employees and generated around $1.58 billion in revenue in 2024. Glenmark Pharmaceuticals was founded in 1977, has an estimated 10,000-50,000 employees, and is headquartered in Mumbai, Maharashtra. On the LightSource stability read it is rated "Established & active": 49 years in operation (founded 1977). 6,206 US import shipments on record. Holds ISO 14001 certification(s) per public sources.
Frequently asked questions
What does Glenmark Pharmaceuticals do?
Glenmark Pharmaceuticals is an Indian multinational pharmaceutical company headquartered in Mumbai, founded in 1977. With 10,000-50,000 employees and estimated annual revenue of $1-5 billion, it operates in branded formulations, generics, active pharmaceutical ingredients, and specialty products across respiratory, dermatology, and oncology segments. The company secured exclusive multi-regional rights to aumolertinib from Hansoh Pharma in late 2025 and operates manufacturing facilities across India, the United States, Argentina, the Czech Republic, and Switzerland.
Where is Glenmark Pharmaceuticals headquartered?
Glenmark Pharmaceuticals is headquartered in Mumbai, Maharashtra (Chhatrapati Shivaji Maharaj Marg, Mumbai, Maharashtra, 400001).
When was Glenmark Pharmaceuticals founded?
Glenmark Pharmaceuticals was founded in 1977.
How big is Glenmark Pharmaceuticals?
Glenmark Pharmaceuticals has an estimated 10,000-50,000 employees, with revenue in the $1-5B range (estimated).
What certifications does Glenmark Pharmaceuticals hold?
Glenmark Pharmaceuticals lists ISO 14001 on its website. Confirm the certified scope for the specific plant producing your part.
Does Glenmark Pharmaceuticals import from overseas suppliers?
US customs bill-of-lading records show 6206 inbound shipments for Glenmark Pharmaceuticals, with top origins including India · Oman · Sri Lanka · Spain.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
